EcoDrugPlus

Protein Tyrosine Phosphatase Receptor Type B

Ensembl ID : ENSPTIG00000010358
Gene Symbol: PTPRB
2 Cross references
264 Possible Orthologues:

Purine Nucleoside Phosphorylase

Ensembl ID : ENSPTIG00000013346
Gene Symbol: PNP
2 Cross references
429 Possible Orthologues:

Purinergic Receptor P2x 3

Ensembl ID : ENSPTIG00000010982
Gene Symbol: P2RX3
2 Cross references
270 Possible Orthologues:

Purinergic Receptor P2x 7

Ensembl ID : ENSPTIG00000016440
Gene Symbol: P2RX7
2 Cross references
187 Possible Orthologues:

Purinergic Receptor P2y1

Ensembl ID : ENSPTIG00000002203
Gene Symbol: P2RY1
2 Cross references
190 Possible Orthologues:

Purinergic Receptor P2y12

Ensembl ID : ENSPTIG00000003600
Gene Symbol: P2RY12
2 Cross references
180 Possible Orthologues:

Pyrimidinergic Receptor P2y4

Ensembl ID : ENSPTIG00000000652
Gene Symbol: P2RY4
2 Cross references
165 Possible Orthologues:

Receptor Interacting Serine/threonine Kinase 1

Ensembl ID : ENSPTIG00000000019
Gene Symbol: RIPK1
2 Cross references
197 Possible Orthologues:

Renin

Ensembl ID : ENSPTIG00000014977
Gene Symbol: REN
2 Cross references
218 Possible Orthologues:

Ret Proto-Oncogene

Ensembl ID : ENSPTIG00000008883
Gene Symbol: RET
2 Cross references
204 Possible Orthologues:

Retinoic Acid Receptor Alpha

Ensembl ID : ENSPTIG00000015995
Gene Symbol: RARA
2 Cross references
331 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSPTIG00000014154
Gene Symbol: RARB
2 Cross references
450 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).